 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 18 | 1/1 | 返回列表 |
| 查看: 1370 | 回復(fù): 17 | |||
[交流]
開發(fā)一種新藥的驚人花費(fèi)（The truly staggering cost of inventing new drugs）
|
|||
|
原文鏈接：http://bioluminor.biomart.cn/news/2770272.htm During the Super Bowl, a representative of the pharmaceutical company Eli Lilly posted the on the company’s corporate blog that the average cost of bringing a new drug to market is $1.3 billion, a price that would buy 371 Super Bowl ads, 16 million official NFL footballs, two pro football stadiums, pay of almost all NFL football players, and every seat in every NFL stadium for six weeks in a row. This is, of course, ludicrous. The average drug developed by a major pharmaceutical company costs at least $4 billion, and it can be as much as $11 billion. The drug industry has been tossing around the $1 billion number for years. It is based largely on a study (supported by drug companies) by Joseph DiMasi of Tufts University. It’s a nice number for the pharmaceutical industry, because it seems to justify the idea that medicines should be pricey (and increasingly, they can be very pricey, costing tens of thousands of dollars per patient per year) without making it seem that inventing new medicines is so expensive an endeavor as to be ultimately futile. But as Bernard Munos of the InnoThink Center for Research In Biomedical Innovation has noted, just adjusting that estimate for current failure rates results in an estimate of $4 billion in research dollars spent for every drug that is approved. But Munos showed me another figure, where he divided each drug company’s R&D budget by the average number of drugs approved. This was far more dramatic. The range of money spent is stunning. AstraZeneca has spent $12 billion in research money for every new drug approved, as much as the top-selling medicine ever generated in annual sales; Amgen spent just $3.7 billion. At $12 billion per drug, inventing medicines is a pretty unsustainable business. At $3.7 billion, you might just be able to make money (a new medicine can probably keep generating revenue for ten years; invent one a year at that rate and you’ll do well). There are lots of expenses here. A single clinical trial can cost $100 million at the high end, and the combined cost of manufacturing and clinical testing for some drugs has added up to $1 billion. But the main expense is failure. AstraZeneca does badly by this measure because it has had so few new drugs hit the market. Eli Lilly spent roughly the same amount on R&D, but got twice as many new medicines approved over that 15 year period, and so spent just $4.5 billion per drug. Wanting to make this even more rigorous, Forbes (that would be Scott DeCarlo and me) took Munos’ count of drug approvals for the major pharmas and combined it with their research and development spending as reported in annual earnings filings going back fifteen years, pulled from a Thomson Reuters database using FactSet. We adjusted all the figures for inflation. Using both drug approvals and research budgets since 1997 keeps the estimates being skewed by short-term periods when R&D budgets or drug approvals changed dramatically. The range of money spent is stunning. AstraZeneca has spent $12 billion in research money for every new drug approved, as much as the top-selling medicine ever generated in annual sales; Amgen spent just $3.7 billion. At $12 billion per drug, inventing medicines is a pretty unsustainable business. At $3.7 billion, you might just be able to make money (a new medicine can probably keep generating revenue for ten years; invent one a year at that rate and you’ll do well). There are lots of expenses here. A single clinical trial can cost $100 million at the high end, and the combined cost of manufacturing and clinical testing for some drugs has added up to $1 billion. But the main expense is failure. AstraZeneca does badly by this measure because it has had so few new drugs hit the market. Eli Lilly spent roughly the same amount on R&D, but got twice as many new medicines approved over that 15 year period, and so spent just $4.5 billion per drug. |
回復(fù)此樓» 猜你喜歡
2026申博推薦
已經(jīng)有1人回復(fù)
-
一篇擴(kuò)散模型的Nature Machine Intelligence論文和Elsevier上的深度學(xué)習(xí)藥物書籍
已經(jīng)有1人回復(fù)
-
藥物學(xué)論文潤色/翻譯怎么收費(fèi)?
已經(jīng)有132人回復(fù)
-
中國藥科大學(xué)2026入學(xué)博士，藥物合成和設(shè)計(jì)經(jīng)驗(yàn)，放射化學(xué)及放射醫(yī)學(xué)研究
已經(jīng)有25人回復(fù)
-
使用MolAICal進(jìn)行多肽虛擬篩選教程-同樣適用于蛋白質(zhì)和核酸的虛擬篩選
已經(jīng)有1人回復(fù)
-
使用MolAICal計(jì)算藥物化學(xué)過濾器MCFs及MCE-18描述符
已經(jīng)有0人回復(fù)
-
使用MolAICal發(fā)現(xiàn)蛋白受體潛在的活性口袋及位點(diǎn)
已經(jīng)有0人回復(fù)
-
華理藥學(xué)學(xué)碩求調(diào)劑，總分324
已經(jīng)有0人回復(fù)
-
澳門理工大學(xué)人工智能藥物發(fā)現(xiàn)中心招收2026級博士研究生（申請-考核制）
已經(jīng)有9人回復(fù)
» 搶金幣啦！回帖就可以得到:
-
祈福2026國基面上項(xiàng)目
+5/350
-
天津理工大學(xué)國家杰青王鐵課題組招收2026年博士研究生
+1/85
-
海南大學(xué)化工院生物質(zhì)定向轉(zhuǎn)化課題組招收博士/碩士，2026年9月入學(xué)
+1/85
-
【代人發(fā)帖勿站內(nèi)信】【成都征男友】89年未婚博士漂亮女孩
+1/69
-
中國藥科大學(xué)211-課題組招收2026博士/碩士
+1/55
-
光學(xué)工程學(xué)碩調(diào)劑信息
+2/46
-
0854電子信息調(diào)劑，閩南師大光電芯片研發(fā)實(shí)驗(yàn)室
+1/42
-
上海交大化院功能大分子團(tuán)隊(duì)招2026年碩士、聯(lián)培、博士后
+1/35
-
青島大學(xué)泰山學(xué)者課題組招2026年申請考核制博士
+1/33
-
Call for paper: [Fermentation – IF 3.3]
+2/14
-
【博士招生】武漢科技大學(xué)招收材料、化工、環(huán)境、冶金類2026年“申請-考核”制博士生
+1/8
-
新加坡國立大學(xué)藥學(xué)系化學(xué)生物學(xué)課題組招PhD
+1/8
-
MTI 380調(diào)劑
+1/8
-
河南大學(xué)龔和貴教授2026年博士研究生招生
+1/7
-
南方科技大學(xué)基礎(chǔ)免疫與微生物學(xué)系招聘科研助理1-2名，從事微生物與免疫學(xué)方向研究
+1/5
-
26年申博自薦-計(jì)算機(jī)視覺
+1/5
-
2026考研的同學(xué)，分?jǐn)?shù)不夠？想調(diào)劑上岸的同學(xué)，來看
+1/4
-
鎮(zhèn)江托爾化學(xué)有機(jī)合成研發(fā)崗位工作機(jī)會
+1/4
-
論文投出，祈福，求好運(yùn)
+1/2
-
浙江大學(xué)高純分離團(tuán)隊(duì)誠聘博士后
+1/2
7樓2015-08-31 16:02:44
9樓2015-09-01 08:14:29
10樓2015-09-01 08:19:15
11樓2015-09-14 11:50:36
★
小木蟲: 金幣+0.5, 給個(gè)紅包，謝謝回帖
小木蟲: 金幣+0.5, 給個(gè)紅包，謝謝回帖
|
本帖內(nèi)容被屏蔽 |
14樓2015-09-17 14:21:15
簡單回復(fù)
dmbb2樓
2015-08-31 14:57
回復(fù)
飛飛-笑笑(金幣+1): 謝謝參與
2015-08-31 15:06
回復(fù)
飛飛-笑笑(金幣+1): 謝謝參與
我是誰博文4樓
2015-08-31 15:15
回復(fù)
飛飛-笑笑(金幣+1): 謝謝參與
2015-08-31 15:27
回復(fù)
飛飛-笑笑(金幣+1): 謝謝參與
一米陽光YM6樓
2015-08-31 15:45
回復(fù)
飛飛-笑笑(金幣+1): 謝謝參與
hr.wu8樓
2015-08-31 16:34
回復(fù)
fishyr12樓
2015-09-17 14:10
回復(fù)
liubopeng13樓
2015-09-17 14:11
回復(fù)
10
小白112615樓
2015-09-17 17:07
回復(fù)
1808466628316樓
2015-09-17 17:22
回復(fù)
xdon041717樓
2015-09-17 22:30
回復(fù)
William.Chen18樓
2015-09-17 23:25
回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 飛飛-笑笑 的主題更新
| 18 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 281求調(diào)劑（0805） +6 | 煙汐憶海 2026-03-16 | 16/800 |
|
|---|---|---|---|---|
|
|
[考研] 321求調(diào)劑 +3 | 何潤采123 2026-03-18 | 3/150 |
|
|
[考研] 085600材料與化工調(diào)劑 324分 +8 | llllkkkhh 2026-03-18 | 8/400 |
|
|
|
[考研] 312求調(diào)劑 +8 | 陌宸希 2026-03-16 | 9/450 |
|
|
|
[考研] 303求調(diào)劑 +4 | 睿08 2026-03-17 | 6/300 |
|
|
|
[考研] 326求調(diào)劑 +5 | 上岸的小葡 2026-03-15 | 6/300 |
|
|
|
[考研] 考研化學(xué)學(xué)碩調(diào)劑，一志愿985 +4 | 張vvvv 2026-03-15 | 6/300 |
|
|
|
[考研] 308求調(diào)劑 +4 | 是Lupa啊 2026-03-16 | 4/200 |
|
|
|
[考研] 332求調(diào)劑 +6 | Zz版 2026-03-13 | 6/300 |
|
|
|
[考研] 有沒有道鐵/土木的想調(diào)劑南林，給自己招師弟中～ +3 | TqlXswl 2026-03-16 | 7/350 |
|
|
|
[考研] 一志愿蘇州大學(xué)材料工程（085601）專碩有科研經(jīng)歷三項(xiàng)國獎(jiǎng)兩個(gè)實(shí)用型專利一項(xiàng)省級立項(xiàng) +6 | 大火山小火山 2026-03-16 | 8/400 |
|
|
|
[考研] 考研調(diào)劑 +3 | 淇ya_~ 2026-03-17 | 5/250 |
|
|
|
[考研] 22408總分284求調(diào)劑 +3 | InAspic 2026-03-13 | 3/150 |
|
|
|
[考研] 070305求調(diào)劑 +3 | mlpqaz03 2026-03-14 | 4/200 |
|
|
|
[考研] 復(fù)試調(diào)劑 +4 | z1z2z3879 2026-03-14 | 5/250 |
|
|
|
[考研] 招收0805（材料）調(diào)劑 +3 | 18595523086 2026-03-13 | 3/150 |
|
|
|
[考研] 311求調(diào)劑 +3 | 冬十三 2026-03-13 | 3/150 |
|
|
|
[考研] 328化工專碩求調(diào)劑 +4 | 。，。，。，。i 2026-03-12 | 4/200 |
|
|
|
[考研] 材料301分求調(diào)劑 +5 | Liyouyumairs 2026-03-12 | 5/250 |
|
|
|
[考研] 0817化學(xué)工程與技術(shù)考研312分調(diào)劑 +3 | T123 tt 2026-03-12 | 3/150 |
|